SOLUTIONS

Our chromatographic solutions for COVID-19 vaccine development

Our chromatographic solutions for COVID-19 vaccine development 

Tosoh Bioscience offers a variety of chromatography resins and columns to support your research and development in the fight against COVID-19.

Contact us to find out, how Tosoh Chromatography solutions help battle COVID-19 »

Check out some of our solutions for analysis and purification of plasmids, viruses, virus like particles, and vaccines:

pic1.jpg

Analysis of oligomerization of recombinant versions of SARS-CoV-2 spike protein S (S, S1 and RBD) expressed in insect cells using TSKgel G5000PWXL SEC columns.

MORE »

pic2.jpg

Rapid method for direct quantification and characterization of enveloped virus-like particles by SEC-UV and SEC-MALS using TSKgel G5000PWXL columns.

MORE »

pic3.jpg Size distribution analysis of influenza virus particles to complement the hemagglutination assay using TSKgel TSKgel G5000PWXL SEC columns. 

MORE »
pic4.jpg

Purification of novel polyethyleneimine-coated adeno-associated virus-like particles for siRNA delivery with TOYOPEARL Butyl-650M HIC resins. 

MORE »

pic5.jpg

Enrichment of supercoiled plasmids by HIC using TOYOPEARL Butyl-650M and plasmid isoform evaluation using TSKgel Butyl-NPR in the production of a herpes simplex vaccine. 

MORE »

pic6.jpg

Purification of a tetravalent virus-like particle vaccine designed to display domains of dengue envelope proteins using TOYOPEARL Phenyl-600M

MORE »